POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (4.20.2021, 10:36am CEST, WHO):   U.S. 38,084    India 259,170    Brazil 42,980    France 29,344    Russia 8,589    The United Kingdom 1,882    Turkey 55,802    Italy 12,688    Poland 7,302    Argentina 16,267    Columbia 16,871    Iran 24,346    Ukraine 6,506    Peru 7,131    Indonesia 4,952    Czechia 2,364    South Africa 1,089    The Netherlands 8,600    Chile 6,622    Canada 7,591    Romania 2,265    Iraq 7,775    Philippines 9,628    Pakistan 5,152    Hungary 2,680    Bangladesh 4,271    Jordan 3,509    Serbia 2,069    Austria 2,159    Japan 3,265    United Arab Emirates 1,803    Malaysia 2,078    Belarus 1,300    Greece 1,829    Azerbaijan 2,144    Tunisia 1,571    Nepal 1,227    Kuwait 1,510    Paraguay 1,801    Ethiopia 1,792    Venezuela 1,287    Oman 1,399    Bahrain 1,008    Uruguay 2,344    Puerto Rico 1,348    Cuba 1,060    Thailand 1,443    China 25    Singapore 20    New Zealand 1    Australia 24    South Korea 549   

Chilean engineer develops early cancer detection system

Staff writer |
Chilean engineer Alejandro Tocigl has developed an early cancer detection system based on a simple blood test,local daily La Tercera reported.

Article continues below






The technology is based on a diagnostic test to detect microRNA, small molecules of genetic material which function as a biomarker for various types of pathologies.

"We are now focusing on the development of this tool for stomach cancer. However, the idea is that in the future, this technology could be applied to other types of cancer and different conditions," Tocigl said at a press conference in Santiago.

Stomach cancer has the highest death rate in Chilean cancer sufferers.

"Early detection and timely treatment increases survival chances over five years to around 90 percent," said the engineer.

Tocigl's company, Miroculus, created the system which mixes a patient's microRNA molecules with specialized chemical compounds. The system then analyzes the molecules and runs a diagnosis to identify correlations with specific conditions.

According to the Image of Chile Foundation, which is Chile's international promotion agency, this test will hopefully be put to broad use in 2018 and will be cheap and accessible.


What to read next

New alternative to colonoscopy is as easy as swallowing pill
Canada reports first-ever cancer stage data
Ovarian cancer is more than one disease